South Korea Active Pharmaceutical Ingredients Market is Segmented By Product Type (Low Potent APIs, High Potent APIs), By Molecular Type (Small Molecu....
Market Size in USD
CAGR5.1%
Study Period | 2024 - 2031 |
Base Year of Estimation | 2023 |
CAGR | 5.1% |
Market Concentration | Medium |
Major Players | Teva Pharmaceutical Industries Ltd., Kyongbo Pharm, SAMOH Pharm. Co., Ltd. , SHINPOONG.CO,.LTD, Kukjeon Pharmaceutical Co., Ltd. |
The South Korea Active Pharmaceutical Ingredients Market is estimated to be valued at USD 6.1 Bn in 2024 and is expected to reach USD 7.9 Bn by 2031, growing at a CAGR of 5.1% from 2024 to 2031.
The market growth is driven by the increasing prevalence of chronic diseases and rising geriatric population in the country.